About

Barry Baumel

Dr. Barry Baumel is a professor at the Department of Neurology, University of Miami School of Medicine, where he specializes in memory and cognitive disorders. He is also the corporate liaison for the American Headache Society and past chair of the American Migraine Foundation. He hopes to continue to improve the lives of headache sufferers through AMF, which he believes is made up of members fully committed to the success of the mission and to improving care, access to care, and appropriate treatment.

Debbie Bohnett

Debbie Bohnett is the Executive Vice President of Private Health Management. As a patient advocate and someone who has experienced migraine herself, she understands the need for researched, relevant and engaging information on migraine. Debbie has over 20 years of experience in upper-level management in several industries, including non-profit, internet, entertainment, retail and restaurant. Her non-profit experience includes serving as President of the Board of Trustees for Camp Ronald McDonald for Good Times and membership on the Board of Directors of Ronald McDonald House Charities of Southern California.

Andrew C. Charles

Paula Dumas

Paula Dumas is the Founder and Managing Editor of Migraine Again, LLC. and Migraine Health Ventures. As a migraine sufferer, she’s lost a decade of days, more than $500,000 in medical expenses, and significant quality of life due to migraine. Through the American Migraine Foundation, she hopes to reach and engage more people, make patient education more relevant and accessible, and shift perceptions around the migraine brand. While ultimately she hopes a cure for migraine is found, in the meantime she wants to empower patients to care for themselves by giving hope and encouragement, and reminding them they’re not alone. She uses her online communities and marketing and leadership skills to advance the fight against migraine and help raise money for research.

Peter J. Goadsby

Dr. Peter Goadsby is the Director of the NIHR-Wellcome Trust King’s Clinical Research Facility, and a professor of Neurology at King’s College London. Previously, he was a professor of Neurology at the University of California, San Francisco.

Deborah Hensheid Lorenz

Deborah Henscheid Lorenz is an intellectual property lawyer at Lorenz & Kop, LLP, and also a long-time migraine sufferer. As a board member with the American Migraine Foundation she serves as a patient advocate, and sees the board as a place where voices like hers can collectively educate the public that migraine is a painful disease and not just a headache. Through advocacy, she hopes migraine will be recognized as a legitimate disease worthy of significant research funds. Her ultimate goal is to help advocate for advanced treatment options that prevent migraines from occurring, without objectionable side effects.

Rachel Irwin Koh

Rachel Irwin Koh is a proven IT professional with more than 20 years of project and program management experience in change initiatives. During her career, Rachel has acquired deep experience navigating politics, leading initiatives and implementing innovative solutions across the complexities of large organizations. Rachel has lived with migraine for 25 years, and it is her personal and professional goal to focus her business, communication, and emotional intelligence skills on patient-focused care initiatives and organizations making a difference in the field of migraine. It is her hope that these goals are met through increased government and private funding, removal of stigmas, and acceptance of migraine as a disability.

Linda McGillicuddy

Linda McGillicuddy is the CEO of the American Headache Society and the American Migraine Foundation. She is grateful for the opportunity to help those with migraine and related diseases, and enjoys developing education for healthcare professionals so they can provide appropriate treatment for migraine. She aims to raise awareness of migraine as a serious condition, so the public will have a greater understanding of what having migraine means.

Kimberly Partain McNamara

Kimberly Partain McNamara, M.S. is a patient advocate who works at Utah Department of Health at the Center for Health Data and Informatics. As a Sr. Research Consultant, she writes, collects, analyzes and reports on a state-wide survey of resident’s health status. Outside of work, she enjoys relaxing with her family, reading and donating her time to the local community as a scout troop leader. Kimberly comes from a long line of family members affected by migraine, and has experience in both supporting a family member and living with the disease herself. With a background in environmental psychology and over 20 years of experience as a research consultant and analyst of health data, Kimberly looks forward to assisting the American Migraine Foundation in its goals to improve the lives of those living with the daily uncertainty of the debilitating effects of this invisible disease.

R. Allan Purdy

Dr. Allan Purdy is the President of the American Headache Society and a Professor of Medicine at Dalhousie University in Halifax, Canada. He is also the Chair of the Education Committee and on the Board of Directors of the International Headache Society. Previously, he was President of the Canadian Headache Society and Head of the Department of Medicine at Dalhousie. Dr. Purdy is interested in the clinical neurology of headache diseases, and in developing educational programs for physicians around the world who care for patients with these diseases. He believes the best care for migraine comes from understanding that it is a neurological disease with remarkable mechanisms embedded in the brain. In 2005, Dr. Purdy received the Arnold P. Friedman Distinguished Clinician Research Award from the American Headache Society for outstanding contribution to the field of headache, and the 2007 Lifetime Achievement Award from the Headache Cooperative of New England.

Todd Schwedt

Ken Shubin Stein

Dr. Shubin Stein is the founder of Spencer Capital Management, LLC. In 2000 he founded Kenshu, LLC, the predecessor to the Spencer Capital Opportunity Fund, LP, which was formed in 2003. From 2001 to 2003 Dr. Shubin Stein managed Kenshu, LLC while also working as a portfolio manager for Promethean Investment Group, LLC. He joined Promethean after completing his internship in orthopedic medicine at Mount Sinai Medical Center in New York. Before his internship, he co-founded and managed Compo Asset Management, LLC, a U.S. based value investment partnership which was merged into Promethean. Prior to founding Compo, Dr. Shubin Stein was a medical technology analyst for The Abernathy Group in New York, an investment management firm specializing in the medical and technology sectors. Dr. Shubin Stein is a graduate of the Albert Einstein College of Medicine where he completed a 5-year medical and research program with a focus on molecular genetics. He graduated with a B.A. degree from Columbia College in 1991 with dual concentrations in Premedical Studies and Political Science. In 2018, he graduated with a Master of Science degree in Epidemiology from the Columbia University Mailman School of Public Health. He also holds a Master of Public Health degree from the Columbia University Mailman School of Public Health. The National Board of Public Health Examiners has recognized Dr. Shubin Stein as Certified in Public Health (CPH). Dr. Shubin Stein is an adjunct professor at the Columbia University Graduate School of Business. Dr. Shubin Stein holds the CFA designation. Dr. Shubin Stein’s commitment to charitable endeavors includes a focus on public health issues and helping homeless/ low-income women and children. He is the co-founder of Crutches 4 Kids, a not-for-profit organization dedicated to providing crutches and other mobility devices to children in need around the world. He is also co-founder of the International Concussion Society. He serves on the board of HelpUSA and is the leader of the organization’s young professionals group, HelpNYC.

Jon Summer

Jon Summer is a migraine patient and the founder of Cyber Group. He brings expertise in strategy, marketing and business growth to the American Migraine Foundation board with the aim to help raise awareness and funding for migraine education and research. He also hopes to provide a patient perspective to discussion surrounding migraine advocacy and treatment in order to find better solutions to stop the suffering for millions of people worldwide. He hopes the next 10 years are full of progress, providing relief that doesn’t carry negative side effects, and more specialists who can provide better and quicker care for those in need.

Richard Wastcoat

Richard Wastcoat is a patient advocate who has worked in the international financial markets for over 35 years. Outside of work, Wastcoat is active on the board of a school and a non-profit in the financial services industry. Wastcoat is based in London and he was drawn to the American Migraine Foundation because he has a family history of migraine and lives with migraine himself. As a member of the AMF board, Wastcoat hopes to use his professional knowledge to link AMF to markets outside the U.S. and to contribute his patient perspective to help others understand and cope with the condition.